Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis.
about
Oral budesonide for induction of remission in ulcerative colitisBudesonide Multi-matrix for the Treatment of Patients with Ulcerative ColitisNext-Generation Therapeutics for IBDBudesonide MMX(®): a review of its use in patients with mild to moderate ulcerative colitis.Ulcerative Colitis: Update on Medical Management.Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or ProctosigmoiditisNew pharmaceuticals in inflammatory bowel diseaseEffectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study.Surgical management of ulcerative colitis in the era of biologicals.Conventional drug therapy for inflammatory bowel disease.Vedolizumab for the treatment of moderately to severely active ulcerative colitis.Positioning Therapy for Ulcerative Colitis.The safety of non-biological treatments in Ulcerative Colitis.Budesonide for the treatment of ulcerative colitis.A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis.Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis.Reviewing treatments and outcomes in the evolving landscape of ulcerative colitis.Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.MMX® technology and its applications in gastrointestinal diseases.Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology.Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis.Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile.Improving IBD Care: A Personalized Approach to Management.
P2860
Q24186368-D44D8DDB-D378-4D18-9FCC-FC75EBD16E0BQ26779042-2942B1FA-4DCC-44F9-A8A9-D9992CEE6F96Q28082306-82D927EB-480E-4AE1-ADE9-12D804459269Q34474024-66CB49D8-E854-450F-973D-44A045CD658AQ35781294-DA3F1860-8336-4124-9A10-F47F2674C688Q36210189-16789460-CEA7-4C02-858E-208DF167F6ADQ36243912-5402C9B2-519A-4619-A644-C471A4A29900Q36919671-C6702488-23E8-4EB2-A837-A2139471205EQ38249428-08C23A48-E8CA-4F2E-96E4-5B8DE3A674CDQ38293796-BDE57BE7-E565-4203-93DF-987AAF277A29Q38425873-BDAC0D2D-D461-4B66-B2A5-39829E711B3DQ38542903-D4B23047-DB24-4C45-9E40-08ABC0D4558BQ38728164-35065076-3E42-4082-90BB-175CBACFC120Q38828972-31B6A51A-3C69-43C4-8CB8-E24878DBA8B6Q38886949-8816EEAF-61FD-4D63-B145-63DF30D1569EQ38960072-2D5A86A6-FC10-495A-B2D0-040384FFFC61Q39251794-E8F9889E-8CED-4927-99B4-861205FA768FQ40046590-E769D274-B20E-4998-8A35-10D6DBC33DD0Q40095211-58518A87-4651-43B0-BE84-BA6A3698B75DQ41582729-07F72863-B8D9-4A94-B7E3-1093DF174727Q42409308-D147AC03-0BE8-44A0-B978-5DCE9429832DQ42695145-2DB5B6F9-AD00-457F-9B3B-A46605BE6C84Q46934021-251B3538-F202-4E4A-BF45-7D86041BBDD4Q47745759-43D47B9A-C3D6-4665-A653-071C280B8832Q53783957-9C051B25-F8D5-4EEA-9773-E6FFA2F211C1Q55512056-E9233FF9-C5F2-4562-A9CC-96C7C74CBB8C
P2860
Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Review article: integrating bu ...... o-moderate ulcerative colitis.
@en
type
label
Review article: integrating bu ...... o-moderate ulcerative colitis.
@en
prefLabel
Review article: integrating bu ...... o-moderate ulcerative colitis.
@en
P2093
P2860
P356
P1476
Review article: integrating bu ...... o-moderate ulcerative colitis.
@en
P2093
C A Siegel
L Peyrin-Biroulet
P2860
P304
P356
10.1111/APT.12712
P407
P577
2014-03-19T00:00:00Z